ResearcherUniversity of UtahNo recent work listed
Joseph E. Biskupiak
Matched on ORCID iD 0000-0002-9436-0984; OpenAlex author ID A5063117371.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 2)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 1
2021: 2 papers
Papers 2
- Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Systematic Review and Indirect Comparison. Last author DOI 10.1159/000517409↗
- Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancreatic cancer in the United States based on… Last author DOI 10.18553/jmcp.2021.27.10.1367↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Aditi A Kharat · 2 shared papers, 2021
- Paper Cost-effectiveness analysis of FOLFIRINOX vs gemcitabine with nab-paclitaxel as adjuvant treatment for resected pancrea… DOI 10.18553/jmcp.2021.27.10.1367↗
- Paper Comparative Safety and Efficacy of Therapeutic Options in Resectable and Advanced/Metastatic Pancreatic Cancer: A Syste… DOI 10.1159/000517409↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.